Colgate-Palmolive Company $CL Shares Bought by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 28.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,847 shares of the company’s stock after acquiring an additional 13,169 shares during the period. Banque Cantonale Vaudoise’s holdings in Colgate-Palmolive were worth $4,729,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of CL. Maseco LLP acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $27,000. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $29,000. Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $30,000. Global Wealth Strategies & Associates raised its position in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares during the last quarter. Finally, Grove Bank & Trust raised its position in shares of Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after purchasing an additional 263 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $90.00 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The firm has a market capitalization of $72.21 billion, a price-to-earnings ratio of 35.02, a PEG ratio of 4.67 and a beta of 0.31. The firm’s fifty day simple moving average is $86.17 and its 200 day simple moving average is $84.92. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same quarter in the previous year, the business posted $0.91 EPS. The firm’s revenue was up 8.4% compared to the same quarter last year. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were paid a $0.53 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CL. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Piper Sandler cut their price objective on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Citigroup lifted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Finally, UBS Group lifted their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.